Pfizer will figure out potential myocarditis risks and long-term safety in participants 5 to 11 years of age when they get around to it.
Categories
Pfizer will figure out potential myocarditis risks and long-term…
Pfizer will figure out potential myocarditis risks and long-term safety in participants 5 to 11 years of age when they get around to it.